Peter Richard Orszag - 15 Sep 2025 Form 4 Insider Report for Lazard, Inc. (LAZ)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
17 Sep 2025, 20:06:50 UTC
Prior SEC filing
19 Aug 2025
Next SEC filing
18 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Peter R. Orszag by Shari L. Soloway under a P of A

Key filing fact

Peter Richard Orszag filed Form 4 for Lazard, Inc. (LAZ) on 17 Sep 2025.

Key facts

  • This page summarizes Peter Richard Orszag's Form 4 filing for Lazard, Inc. (LAZ).
  • 4 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 17 Sep 2025, 20:06.

Change

  • Previous filing in this sequence was filed on 19 Aug 2025.
  • Current net transaction value: -$2,839,744.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001837678 Primary reporting owner

Orszag Peter Richard

Relationship
CEO & Chairman, Director
Address
C/O LAZARD, INC., 30 ROCKEFELLER PLAZA, NEW YORK
Signature
/s/ Peter R. Orszag by Shari L. Soloway under a P of A
Signature date
17 Sep 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LAZ transaction

Common Stock

Options Exercise

Transaction value
Shares
+64,949
Change %
+38%
Price
Shares after
235,234
Date
15 Sep 2025
Ownership
Direct
Footnotes
F1
LAZ transaction

Common Stock

Disposed to Issuer

Transaction value
$1,083,171
Shares
-19,485
Change %
-8.3%
Price
$55.59
Shares after
215,749
Date
15 Sep 2025
Ownership
Direct
Footnotes
F2, F3
LAZ transaction

Common Stock

Sale

Transaction value
$1,756,573
Shares
-32,475
Change %
-15%
Price
$54.09
Shares after
183,274
Date
16 Sep 2025
Ownership
Direct
Footnotes
F4, F5

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LAZ transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-64,949
Change %
-100%
Price
$0.000000
Shares after
0
Date
15 Sep 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
64,949
Exercise price
Footnotes
F1, F6, F7, F8
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 8 footnotes

Footnote F1

Shares of Common Stock were acquired upon the exchange of a prior grant of Restricted Stock Units ("RSUs") into shares of Common Stock.

Footnote F2

Represents shares of Common Stock sold to the Company to cover estimated taxes.

Footnote F3

Represents the New York Stock Exchange closing price of Common Stock on the trading day immediately preceding the exchange date of the RSUs referenced in Footnote (6).

Footnote F4

This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025. Sales of shares pursuant to the plan are intended to cover estimated taxes and other personal expenditures.

Footnote F5

The price reported in Column 4 is the weighted average price. The shares were sold in multiple transactions that were executed on September 16, 2025 in trades with average execution prices ranging from $53.76 to $54.53 inclusive. The Reporting Person undertakes to provide the issuer, any security holder of the issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the price ranges set forth in this report.

Footnote F6

Represents a prior grant of RSUs awarded for which service and other conditions have been satisfied.

Footnote F7

Each RSU represents a contingent right to receive one share of Common Stock.

Footnote F8

Amount excludes a prior grant of 1,250,000 Stock Price Performance-based Restricted Participation Units and 306,546 Restricted Participation Units, each of which was reflected in the Company's proxy statement for the relevant year.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .